WallStreetZenWallStreetZen

NYSE: ELV
Elevance Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ELV

Based on 14 analysts offering 12 month price targets for Elevance Health Inc

Min Forecast
$297.00-6.37%
Avg Forecast
$385.86+21.64%
Max Forecast
$478.00+50.69%

Should I buy or sell ELV stock?

Based on 14 analysts offering ratings for Elevance Health Inc.

Buy
Strong Buy
7 analysts 50%
Buy
2 analysts 14.29%
Hold
5 analysts 35.71%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ELV's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ELV as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ELV stock forecasts and price targets.

ELV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-28
lockedlocked$00.00+00.00%2025-10-23
lockedlocked$00.00+00.00%2025-10-22
lockedlocked$00.00+00.00%2025-10-22
lockedlocked$00.00+00.00%2025-10-14
Goldman Sachs
Top 13%
88
HoldInitiates Coverage On$343.00+8.13%2025-10-14
Bank of America
Bottom 49%
49
HoldMaintains$370.00+16.65%2025-10-10
Mizuho
Top 9%
92
BuyMaintains$420.00+32.41%2025-10-09
Guggenheim
Bottom 8%
8
Strong BuyMaintains$398.00+25.47%2025-10-08
UBS
Top 12%
89
Strong BuyMaintains$425.00+33.98%2025-09-05

1 of 2

Forecast return on equity

Is ELV forecast to generate an efficient return?

Company
21.97%
Industry
24.07%
Market
146.76%
ELV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ELV forecast to generate an efficient return on assets?

Company
7.87%
Industry
7.22%
ELV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ELV earnings per share forecast

What is ELV's earnings per share in the next 3 years based on estimates from 26 analysts?

Avg 1 year Forecast
$30.27+23.22%
Avg 2 year Forecast
$27.58+12.26%
Avg 3 year Forecast
$31.77+29.3%
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ELV revenue forecast

What is ELV's revenue in the next 3 years based on estimates from 22 analysts?

Avg 1 year Forecast
$200.2B+2.75%
Avg 2 year Forecast
$206.6B+6.06%
Avg 3 year Forecast
$217.0B+11.37%
ELV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ELV earnings growth forecast

How is ELV forecast to perform vs Healthcare Plans companies and vs the US market?

Company
7.23%
Industry
32.71%
Market
41.92%
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ELV's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ELV revenue growth forecast

How is ELV forecast to perform vs Healthcare Plans companies and vs the US market?

Company
3.53%
Industry
3.81%
Market
26.17%
ELV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ELV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ELV vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
ELV$317.20$385.86+21.64%Buy
CI$244.41$374.64+53.28%Strong Buy
CVS$78.15$90.08+15.26%Strong Buy
HUM$278.19$298.58+7.33%Buy
CNC$35.37$37.33+5.55%Hold
View Top Healthcare Plan Stocks

Elevance Health Stock Forecast FAQ

Is Elevance Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NYSE: ELV) stock is to Buy ELV stock.

Out of 14 analysts, 7 (50%) are recommending ELV as a Strong Buy, 2 (14.29%) are recommending ELV as a Buy, 5 (35.71%) are recommending ELV as a Hold, 0 (0%) are recommending ELV as a Sell, and 0 (0%) are recommending ELV as a Strong Sell.

If you're new to stock investing, here's how to buy Elevance Health stock.

What is ELV's earnings growth forecast for 2025-2027?

(NYSE: ELV) Elevance Health's forecast annual earnings growth rate of 7.23% is not forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 32.71%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.92%.

Elevance Health's earnings in 2025 is $5,533,000,000.On average, 26 Wall Street analysts forecast ELV's earnings for 2025 to be $6,728,189,654, with the lowest ELV earnings forecast at $6,461,947,616, and the highest ELV earnings forecast at $7,035,523,640. On average, 26 Wall Street analysts forecast ELV's earnings for 2026 to be $6,130,034,024, with the lowest ELV earnings forecast at $5,335,952,700, and the highest ELV earnings forecast at $7,371,548,649.

In 2027, ELV is forecast to generate $7,060,147,695 in earnings, with the lowest earnings forecast at $6,130,900,755 and the highest earnings forecast at $8,678,312,576.

What is ELV's revenue growth forecast for 2025-2027?

(NYSE: ELV) Elevance Health's forecast annual revenue growth rate of 3.53% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 3.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.17%.

Elevance Health's revenue in 2025 is $194,820,000,000.On average, 22 Wall Street analysts forecast ELV's revenue for 2025 to be $44,486,422,144,762, with the lowest ELV revenue forecast at $42,834,299,180,620, and the highest ELV revenue forecast at $46,906,824,512,595. On average, 22 Wall Street analysts forecast ELV's revenue for 2026 to be $45,918,528,733,534, with the lowest ELV revenue forecast at $43,018,757,353,910, and the highest ELV revenue forecast at $49,040,316,637,395.

In 2027, ELV is forecast to generate $48,219,144,408,110 in revenue, with the lowest revenue forecast at $44,268,628,157,022 and the highest revenue forecast at $51,663,622,995,847.

What is ELV's forecast return on assets (ROA) for 2025-2028?

(NYSE: ELV) forecast ROA is 7.87%, which is higher than the forecast US Healthcare Plans industry average of 7.22%.

What is ELV's Price Target?

According to 14 Wall Street analysts that have issued a 1 year ELV price target, the average ELV price target is $385.86, with the highest ELV stock price forecast at $478.00 and the lowest ELV stock price forecast at $297.00.

On average, Wall Street analysts predict that Elevance Health's share price could reach $385.86 by Oct 28, 2026. The average Elevance Health stock price prediction forecasts a potential upside of 21.64% from the current ELV share price of $317.20.

What is ELV's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: ELV) Elevance Health's current Earnings Per Share (EPS) is $24.57. On average, analysts forecast that ELV's EPS will be $30.27 for 2025, with the lowest EPS forecast at $29.08, and the highest EPS forecast at $31.66. On average, analysts forecast that ELV's EPS will be $27.58 for 2026, with the lowest EPS forecast at $24.01, and the highest EPS forecast at $33.17. In 2027, ELV's EPS is forecast to hit $31.77 (min: $27.59, max: $39.05).

What is ELV's forecast return on equity (ROE) for 2025-2028?

(NYSE: ELV) forecast ROE is 21.97%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.